Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ACTAVIS INC
05/15 ACTAVIS : Eli Lilly loses Alimta patent case to Actavis
05/14DJFOREST LABORATORIES : Labs' Saunders to Head Actavis After Deal
05/12 ACTAVIS : Announces Acanya® Gel Patent Challenge Settlement
05/07 ACTAVIS : Launches Generic Version of Catapres-TTS®
05/06 Factbox - M&A frenzy transforming global pharma
05/06 M&A frenzy in healthcare sector
05/05 ACTAVIS : and Forest Announce Effectiveness of Registration Statement on Form S-..
05/02 EXCLUSIVE : Abbott taps Morgan Stanley to sell mature products - sources
05/01 Pfizer's designs on AstraZeneca stir tax envy among rivals
04/30 ACTAVIS : Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-..
04/28 Pfizer move to join tax-driven deal-making raises red flags in U.S
04/28 Pfizer move to join tax-driven deal-making raises red flags in U.S
04/28 ACTAVIS : Sues FDA Regarding Delay of Generic Celebrex® Approval
04/24 EXCLUSIVE - ALLERGAN APPROACHED SHIR : sources
04/24DJActavis Settles Celebrex Case With Pfizer -- Update
04/24 ACTAVIS : Announces Celebrex® Patent Challenge Settlement
04/21 ACTAVIS : Announces Departure of G. Frederick Wilkinson, President, Actavis Glob..
04/17 ACTAVIS : and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Ro..
04/14 Investors support deals spree, happy to see U.S. companies buy growth
04/02 ACTAVIS : Launches Asia Pacific Regional Headquarters in Singapore
04/01 ACTAVIS : Particle Sciences and Actavis Enter into Joint Development Agreement
04/01 ACTAVIS : Acquires Silom Medical Company
04/01 ACTAVIS : Completes Divestiture of Commercial Operations in Seven Western Europe..
03/28 ACTAVIS : Confirms Favorable Ruling in Generic Lialda® Patent Suit
03/27 A string of mega deals drives global M&A recovery in first-quarter
03/21 ACTAVIS : to Host First Quarter 2014 Earnings Conference Call and Webcast
03/21 ACTAVIS : Pharmaceutical Equities under Review -- Research on Zoetis, Mylan, AVA..
03/19 ACTAVIS : Announces Daytrana® Patent Challenge Settlement
03/18 Insight - Unease grows among U.S. doctors over Indian drug quality
03/13DJMylan Plans to Start Selling Generic Celebrex in May
03/12 ACTAVIS PLC : Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit
03/12DJPfizer Says Court Invalidates Celebrex Patent
03/04 ACTAVIS PLC : Actavis to Present at Barclays Global Healthcare Conference
02/28 ACTAVIS PLC : Actavis Confirms Generic Colcrys® Patent Challenge
02/28 ACTAVIS PLC : Actavis Confirms Generic Multaq® Patent Challenge
02/24DJMARKET SNAPSHOT : Stocks Rally; S&P 500 Ends Right Below Record
02/24DJMARKET SNAPSHOT : U.S. Stocks Rally As S&P 500 Hits Intraday Record
02/24DJMARKET SNAPSHOT : U.S. Stock Market Is Starting To Ride A Tech M&A Wave
02/23DJMARKET SNAPSHOT : U.S. Stock Market Is Starting To Ride A Tech M&A Wave
02/20 Goldman Sachs misses out on WhatsApp, 2014's top deals so far
02/20DJU.S. HOT STOCKS : Hot Stocks to Watch
02/20 ACTAVIS PLC : Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quar..
02/19 ACTAVIS PLC : Actavis to Present at Citi's 2014 Global Healthcare Conference
02/19 ACTAVIS PLC : Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires ..
02/18 CARL ICAHN : Icahn says Actavis-Forest deal validates shareholder activism
02/18 ACTAVIS PLC : Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Schedule..
02/18DJMARKET SNAPSHOT : U.S. Stocks Edge Up; Nasdaq Gains For 8th Day In A Row
02/18 CARL ICAHN : Actavis to buy Forest for $25 billion; windfall for investor Icahn
02/18DJMARKET SNAPSHOT : U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq Gains
02/18DJMARKET SNAPSHOT : U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq Gains
02/18DJMARKET SNAPSHOT : U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq Gains
02/18DJMARKET SNAPSHOT : U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq Gains
02/18DJMARKET SNAPSHOT : U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq Gains
02/18 Actavis to buy Forest for $25 billion; windfall for investor Icahn
02/18DJMARKET SNAPSHOT : U.S. Stock Gains Muted By Data; Coke Weighs On Dow
02/18DJMARKET SNAPSHOT : U.S. Stocks Edge Lower After Weak Data
02/18DJMARKET SNAPSHOT : U.S. Stocks Edge Lower After Weak Data
02/18DJMARKET SNAPSHOT : U.S. Stocks Edge Higher; Manufacturing Data Weighs
02/18 ACTAVIS PLC : Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in a..
02/18 Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ
02/11 ACTAVIS PLC : Actavis to Host Fourth Quarter 2013 Earnings Conference Call and W..
02/04 ACTAVIS PLC : Actavis Confirms Generic Treanda® Patent Challenge
01/31DJU.S. HOT STOCKS : Hot Stocks to Watch
01/31 ACTAVIS PLC : Actavis Presents Outlook for Continued Long-Term Growth
01/31 ACTAVIS PLC : Actavis Announces Refocused Global Business Structure to Maximize ..
01/24 ACTAVIS PLC : Actavis Announces Agreement with Zhejiang Chiral Medicine Chemical..
01/22 ACTAVIS PLC : Actavis Comments on Notification to Allergan, Inc. of Submission o..
01/17 ACTAVIS PLC : Actavis Announces Agreement with Aurobindo Pharma Limited to Dives..
01/17 ACTAVIS PLC : Actavis Confirms Court Upholds Lo Loestrin® Fe Patent
01/14 ACTAVIS PLC : Actavis Announces Preliminary Financial Performance for FY 2013
01/14 ACTAVIS PLC : Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands B..
01/14DJValeant, Actavis, Mylan Said Interested in Buying Pfizer's Generics Unit -- R..
01/14 EXCLUSIVE : Valeant, Actavis, Mylan eye Pfizer's generics unit: sources
01/14 EXCLUSIVE : Valeant, Actavis, Mylan eye Pfizer's generics unit - sources
01/08 ACTAVIS PLC : Actavis' Generic Version of Micardis® Receives FDA Approval
Prev.1   2  3  4  5  6  7  8Next
Advertisement
Dynamic quotes  
ON
| OFF